Lupus · Minneapolis

Lupus clinical trials in Minneapolis

2 recruiting systemic lupus erythematosus studies within range of Minneapolis. Click any trial for full eligibility criteria and contact info.

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297 · Systemic Lupus Erythematosus, Lupus Nephritis

Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

PhasePhase 1 / Phase 2

TypeInterventional

Age18 Years – 65 Years

WhereOrange, California, United States + 22 more

SponsorCabaletta Bio

▾Tap for detailsClick for full details — eligibility, all locations, contacts

23 sitesApply

Apply Open full pageClinicalTrials.gov ↗

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

NCT06308978 · Antineutrophilic Cytoplasmic Antibody (ANCA)- Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Systemic Sclerosis (SSc)

Recruiting

This is a phase 1 study designed to evaluate the safety, pharmacokinetics (PK), and anti-B-cell activity of FT819 following treatment with or without auxiliary medicinal product (AMP) in participants with moderate to severe active systemic lupus erythematosus (SLE), antineutrophilic cytoplasmic antibody (ANCA)-associated vasculitis (AAV), idiopathic inflammatory myositis (IIM), and systemic sclerosis (SSc). The study will consist of a dose-escalation stage, followed by an expansion stage to further evaluate the safety and activity of FT819.

PhasePhase 1

TypeInterventional

Age12 Years – 70 Years

WhereFullerton, California, United States + 16 more

SponsorFate Therapeutics

▾Tap for detailsClick for full details — eligibility, all locations, contacts

17 sitesApply

Apply Open full pageClinicalTrials.gov ↗

← All systemic lupus erythematosus trials (nationwide)